MOLLI® 2 System offers breast cancer patients
unmatched surgical precision and enhanced comfort
BOSTON, July 18,
2024 /PRNewswire/ -- MOLLI Surgical is proud to
announce that breast surgeons at Tufts Medical Center, a leading
academic medical center in Massachusetts, are adopting the MOLLI® 2
System. The technology is also being used at fellow Tufts Medicine
site, MelroseWakefield Hospital. MOLLI Surgical's wire-free and
radiation-free technology for localizing lesions for breast cancer
surgery improves the patient experience and has earned praise from
surgeons for its accuracy and ease of use.
"At Tufts Medical Center, we are always searching for new
innovations and technologies to provide an enhanced patient
experience that doesn't sacrifice efficiency and accuracy," said
Abhishek Chatterjee, MD, Chief of
the Division of Plastic Surgery at Tufts Medical Center. "It's
always an added benefit when there is a seamless implementation
that makes the transition easy for surgeons, radiologists and the
surgical support team."
The MOLLI 2 System is an innovative technology that allows
radiologists to mark lesions with the MOLLI® Marker, a localization
device roughly the size of a sesame seed. Surgeons then use the
MOLLI® Wand and MOLLI® Tablet to locate the lesion marked in
radiology reliably. The technology features a market-leading
innovation — directional 3D guidance — which enables MOLLI 2 to
direct surgeons to the lesion with millimeter precision. The MOLLI
2 System is easy to use, reliable, and precise, improving
efficiency and enhancing the patient experience.
"Our goal in designing and building the MOLLI 2 System is to
drastically improve the patient experience through simple,
effective, and safe precision surgery technology," said
Ananth Ravi, President and CEO of
MOLLI Surgical. "We're thrilled to partner with Tufts Medical
Center as we both share the same commitment to patients and
providing innovative, best-in-class breast cancer treatment that
keeps the patient experience at the forefront."
This collaboration underscores the commitment of Tufts Medical
Center and MOLLI Surgical to enabling precision surgery made
simpler, elevating clinical efficiency, and enhancing the patient
and physician experience.
About MOLLI Surgical:
MOLLI Surgical started with
one patient, who asked if there was a way to make her breast cancer
journey better. Her voice led to the creation of our flagship wire
and radiation-free technologies — MOLLI® 2 and MOLLI re.markable™.
Our innovations are intended to replace outdated procedures to mark
lesions for surgical removal through greater precision, efficiency,
and cost-effectiveness. We are obsessed with every detail of our
design process to ensure surgeons and radiologists have the best
possible tools to support an improved patient experience.
MOLLI® has been recognized by TIME as one of 2022's "Best
Inventions" in the Medical Care category and named to Fast
Company's list of "Next Big Things in Tech," recognizing
technological breakthroughs across industries that promise to
transform the future. We are proud to build the advanced solutions
that patients and physicians prefer. Follow us on Facebook,
LinkedIn, X, and YouTube.
Press Contact:
Grace
Halvorsen
gracehalvorsen@lightspeedpr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tufts-medical-center-becomes-first-hospital-in-massachusetts-to-adopt-molli-surgicals-breast-cancer-technology-302198646.html
SOURCE MOLLI Surgical